Recent Evidence for Fixed-Ratio Combinations of Basal Insulin and GLP-1 RA vs. Basal-Bolus Insulin in T2D: Updates from ADA 2022
Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1 RA) have demonstrated maintenance of HbA1c efficacy, less hypoglycemia, and weight loss compared to basal-...
1 Okt 202214min
Practical Tips to Interpreting Continuous Glucose Monitoring Metrics
With newer technologies being used to monitor blood glucose levels, how can we use data from continuous glucose monitoring (CGM) to inform the day-to-day management of diabetes?Our host, Dr. Ronald Go...
1 Okt 202221min
Glucose Variability Results from the InRange Study
Metrics beyond HbA1c such as glucose variability are emerging as key parameters that can help guide the daily management of diabetes, but what is the clinical relevance of such measures, particularly ...
8 Sep 202213min
Prime Time for InRange: Comparison of Insulin Glargine 300 U/mL vs. Degludec 100 U/mL in Type 1 Diabetes
Continuous glucose monitoring (CGM) metrics are emerging as key parameters that can help guide the management of diabetes, but how can they be applied in clinical practice, particularly for those with...
8 Sep 202216min
